Lukas Scheibler's Net Worth

$7.7 Million

Estimate Recalculated Jul 1, 2024 03:04PM EST

Who is Lukas Scheibler?

Lukas Scheibler has an estimated net worth of $7.7 Million. This is based on reported shares across multiple companies, which include KUBOTA PHARMACEUTICAL HOLDINGS CO LTD, and Apellis Pharmaceuticals, Inc..

SEC CIK

Lukas Scheibler's CIK is 0001651281

Past Insider Trading and Trends

2017 was Lukas Scheibler's most active year for acquiring shares with 9 total transactions. Lukas Scheibler's most active month to acquire stocks was the month of December. 2022 was Lukas Scheibler's most active year for disposing of shares, totalling 21 transactions. Lukas Scheibler's most active month to dispose stocks was the month of March. 2023 saw Lukas Scheibler paying a total of $2,006,455.52 for 91,961 shares, this is the most they've acquired in one year. In 2022 Lukas Scheibler cashed out on 102,303 shares for a total of $2,431,161.36, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

KUBOTA PHARMACEUTICAL HOLDINGS CO LTD No price found

EVP Research & Development

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+14.57%
1.41K
$6.50
-$8,125.00
11.11K
Jul 17
Form 4
+16.37%
1.36K
$6.95
-$9,035.00
9.7K
Jun 17 - Jun 20
Form 4
+19.99%
1.39K
$6.15
-$7,841.25
8.33K
May 17
Form 4
+24.00%
1.34K
$6.48
-$8,553.60
6.94K
Apr 17
Form 4
+33.76%
1.41K
$7.10
-$8,875.00
5.6K
Mar 17 - Mar 20
Form 4
+40.85%
1.21K
$8.10
-$11,745.00
4.19K
Feb 17
Form 4
+66.59%
1.19K
$8.70
-$12,832.50
2.97K
Jan 17 - Jan 18
Form 4
∞
1.78K
$8.18
-$7,198.40
1.78K
Dec 22
Form 4
—
0
$9.35
-$24,890.53
0
Nov 17 - Nov 21
Form 4
-100.00%
-1.77K
$9.44
-$16,745.50
0
Nov 14
Form 4
∞
1.77K
$11.48
-$10,220.31
1.77K
Oct 17
Form 4
—
0
$9.53
-$25,381.59
0
Sep 17 - Sep 20
Form 4
—
0
$10.81
-$345,509.22
0
Aug 17 - Aug 18
Form 4
—
0
—
—
0
Jul 12
Form 4
—
0
—
—
0
Aug 17
Form 3
—
0
—
—
0
No matching records found

Apellis Pharmaceuticals, Inc. (APLS) Snapshot price: $68

Chief Research Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$36.92
-$461,500.00
68.3K
Scheduled
Dec 1
Form 4
-2.51%
-1.76K
$43.01
-$75,525.56
68.3K
Sep 6
Form 4
+15.17%
9.17K
$58.50
-$41,827.50
69.64K
Feb 21
Form 4
-1.11%
-678.00
$51.21
-$34,720.38
60.47K
Feb 10
Form 4
-0.88%
-542.00
$52.77
-$28,601.34
61.15K
Jan 27
Form 4
-3.16%
-2.02K
$52.05
-$104,880.75
61.69K
Jan 20
Form 4
+54.90%
22.58K
—
—
63.71K
Jan 12
Form 4
-22.73%
-11.88K
$43.00
-$430,000.00
40.36K
Apr 21 - May 27
Form 4
—
0
$36.97
-$28,158.33
52.23K
Apr 5
Form 4
—
0
$35.41
-$151,058.73
52.23K
Apr 4
Form 4
—
0
$34.45
-$473,635.20
52.23K
Apr 1
Form 4
+1.40%
720
$26.73
$19,245.60
52.23K
Feb 14
Form 4
-3.13%
-1.67K
$46.80
-$77,968.80
51.51K
Feb 11
Form 4
-1.26%
-678.00
$31.84
-$393,447.36
53.18K
Feb 10
Form 4
—
0
$29.43
-$311,500.00
53.86K
Feb 8
Form 4
-3.36%
-1.88K
$38.51
-$72,208.29
53.86K
Jan 28 - Jan 31
Form 4
+87.77%
26.05K
—
—
55.73K
Jan 21
Form 4
+11.33%
3.02K
$26.73
$80,751.33
29.68K
Jan 21
Form 4
-11.36%
-3.42K
$60.00
-$205,020.00
26.65K
Jun 10
Form 4
-2.27%
-680.00
$47.72
-$32,449.60
29.29K
Feb 10
Form 4
+45.52%
9.38K
—
—
29.97K
Jan 28
Form 4
+57.06%
7.48K
$26.73
$199,993.86
20.59K
Dec 8
Form 4
+319.42%
9.38K
—
—
12.31K
Feb 10
Form 4
—
0
—
—
0
Feb 8
Form 4
∞
2.94K
$20.37
$59,785.95
2.94K
May 24
Form 4
—
0
—
—
0
Apr 13
Form 3
—
0
—
—
0
No matching records found